Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference

Sep 06, 2018

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Morgan Stanley 2018 Global Health Care Conference on Thursday, September 13, 2018, in New York. Giovanni Caforio, M.D., chairman and chief executive officer will make formal remarks about the company and answer questions at 11:10 a.m. EDT.

Investors and the general public are invited to listen to a live webcast of the session at Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at or follow us on LinkedInTwitter, YouTube and Facebook.

Bristol-Myers Squibb
Lisa McCormick Lavery, 609-252-7602
Tim Power, 609-252-7509
Bill Szablewski, 609-252-5894

Source: Bristol-Myers Squibb Company